Does TACROLIMUS Cause Tubulointerstitial nephritis? 486 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 486 reports of Tubulointerstitial nephritis have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.5% of all adverse event reports for TACROLIMUS.
486
Reports of Tubulointerstitial nephritis with TACROLIMUS
0.5%
of all TACROLIMUS reports
21
Deaths
198
Hospitalizations
How Dangerous Is Tubulointerstitial nephritis From TACROLIMUS?
Of the 486 reports, 21 (4.3%) resulted in death, 198 (40.7%) required hospitalization, and 18 (3.7%) were considered life-threatening.
Is Tubulointerstitial nephritis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 486 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Tubulointerstitial nephritis?
OMEPRAZOLE (4,809)
ESOMEPRAZOLE (4,024)
LANSOPRAZOLE (3,860)
PANTOPRAZOLE (3,590)
DEXLANSOPRAZOLE (2,177)
RABEPRAZOLE (1,125)
PEMBROLIZUMAB (860)
IBUPROFEN (844)
VANCOMYCIN (523)
NIVOLUMAB (467)
Which TACROLIMUS Alternatives Have Lower Tubulointerstitial nephritis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB